JP2012512874A5 - - Google Patents

Download PDF

Info

Publication number
JP2012512874A5
JP2012512874A5 JP2011542276A JP2011542276A JP2012512874A5 JP 2012512874 A5 JP2012512874 A5 JP 2012512874A5 JP 2011542276 A JP2011542276 A JP 2011542276A JP 2011542276 A JP2011542276 A JP 2011542276A JP 2012512874 A5 JP2012512874 A5 JP 2012512874A5
Authority
JP
Japan
Prior art keywords
acceptable salt
pharmaceutical composition
pharmaceutically acceptable
compound according
diabetes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011542276A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012512874A (ja
JP5497064B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/067603 external-priority patent/WO2010080333A1/en
Publication of JP2012512874A publication Critical patent/JP2012512874A/ja
Publication of JP2012512874A5 publication Critical patent/JP2012512874A5/ja
Application granted granted Critical
Publication of JP5497064B2 publication Critical patent/JP5497064B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011542276A 2008-12-19 2009-12-11 グルコキナーゼ活性化因子として有用なアリールシクロプロピルアセトアミド誘導体 Active JP5497064B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP08380341.1 2008-12-19
EP08380341 2008-12-19
US15378109P 2009-02-19 2009-02-19
US61/153,781 2009-02-19
PCT/US2009/067603 WO2010080333A1 (en) 2008-12-19 2009-12-11 Arylcyclopropylacetamide derivatives useful as glucokinase activators

Publications (3)

Publication Number Publication Date
JP2012512874A JP2012512874A (ja) 2012-06-07
JP2012512874A5 true JP2012512874A5 (cg-RX-API-DMAC10.html) 2013-01-24
JP5497064B2 JP5497064B2 (ja) 2014-05-21

Family

ID=40545955

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011542276A Active JP5497064B2 (ja) 2008-12-19 2009-12-11 グルコキナーゼ活性化因子として有用なアリールシクロプロピルアセトアミド誘導体

Country Status (34)

Country Link
US (1) US8063079B2 (cg-RX-API-DMAC10.html)
EP (1) EP2379517B1 (cg-RX-API-DMAC10.html)
JP (1) JP5497064B2 (cg-RX-API-DMAC10.html)
KR (1) KR101290437B1 (cg-RX-API-DMAC10.html)
CN (1) CN102256952B (cg-RX-API-DMAC10.html)
AR (1) AR074470A1 (cg-RX-API-DMAC10.html)
AU (1) AU2009335931B2 (cg-RX-API-DMAC10.html)
BR (1) BRPI0923183B1 (cg-RX-API-DMAC10.html)
CA (1) CA2746746C (cg-RX-API-DMAC10.html)
CO (1) CO6382120A2 (cg-RX-API-DMAC10.html)
CR (1) CR20110342A (cg-RX-API-DMAC10.html)
DK (1) DK2379517T3 (cg-RX-API-DMAC10.html)
DO (1) DOP2011000197A (cg-RX-API-DMAC10.html)
EA (1) EA019055B1 (cg-RX-API-DMAC10.html)
EC (1) ECSP11011150A (cg-RX-API-DMAC10.html)
ES (1) ES2435242T3 (cg-RX-API-DMAC10.html)
HR (1) HRP20130983T1 (cg-RX-API-DMAC10.html)
IL (1) IL213210A (cg-RX-API-DMAC10.html)
JO (1) JO2979B1 (cg-RX-API-DMAC10.html)
MA (1) MA32902B1 (cg-RX-API-DMAC10.html)
MX (1) MX2011006434A (cg-RX-API-DMAC10.html)
MY (1) MY180567A (cg-RX-API-DMAC10.html)
NZ (1) NZ592930A (cg-RX-API-DMAC10.html)
PA (1) PA8851901A1 (cg-RX-API-DMAC10.html)
PE (1) PE20120339A1 (cg-RX-API-DMAC10.html)
PL (1) PL2379517T3 (cg-RX-API-DMAC10.html)
PT (1) PT2379517E (cg-RX-API-DMAC10.html)
SG (1) SG172256A1 (cg-RX-API-DMAC10.html)
SI (1) SI2379517T1 (cg-RX-API-DMAC10.html)
TN (1) TN2011000294A1 (cg-RX-API-DMAC10.html)
TW (1) TWI395748B (cg-RX-API-DMAC10.html)
UA (1) UA104742C2 (cg-RX-API-DMAC10.html)
WO (1) WO2010080333A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA201103944B (cg-RX-API-DMAC10.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2800498C (en) 2010-03-31 2021-11-16 The Scripps Research Institute Reprogramming cells
WO2015075942A1 (ja) * 2013-11-22 2015-05-28 国立大学法人 東京大学 薬剤送達用のキャリア、コンジュゲートおよびこれらを含んでなる組成物並びにこれらの投与方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1282612B1 (en) 2000-05-03 2004-12-29 F. Hoffmann-La Roche Ag Alkynyl phenyl heteroaromatic glucokinase activators
BR0110704A (pt) 2000-05-08 2003-01-28 Hoffmann La Roche Fenil - acetamidas substituìdas e seu uso como ativadores de glicocinase
MXPA02010795A (es) 2000-05-08 2003-03-27 Hoffmann La Roche Activadores de glucocinasa de fenilamida sustituida por para-amino.
MY141521A (en) * 2002-12-12 2010-05-14 Hoffmann La Roche 5-substituted-six-membered heteroaromatic glucokinase activators
WO2004063179A1 (en) 2003-01-06 2004-07-29 Eli Lilly And Company Substituted arylcyclopropylacetamides as glucokinase activators
JP4621198B2 (ja) 2003-02-11 2011-01-26 プロシディオン・リミテッド トリ(シクロ)置換アミドグルコキナーゼ活性化化合物
PL378117A1 (pl) 2003-02-11 2006-03-06 Prosidion Limited Tricyklopodstawione związki amidowe
WO2004076420A1 (ja) * 2003-02-26 2004-09-10 Banyu Pharmaceutical Co., Ltd. ヘテロアリールカルバモイルベンゼン誘導体
EA012204B1 (ru) 2004-04-21 2009-08-28 Прозидион Лимитед Три(цикло)замещённые амидные соединения
MX2007001650A (es) 2004-08-12 2007-07-13 Prosidion Ltd Fenilacetamidas substituidas y su uso como activadores de glucocinasa.
AU2005311269B2 (en) * 2004-12-03 2011-11-10 Transtech Pharma, Inc. Heteroaromatic glucokinase activators
BRPI0612582A2 (pt) 2005-07-01 2010-11-23 Novartis Ag combinação de compostos orgánicos
RU2420525C2 (ru) 2005-07-11 2011-06-10 Мицубиси Танабе Фарма Корпорейшн Производные оксимов и их получение
WO2007017649A1 (en) * 2005-08-09 2007-02-15 Astrazeneca Ab Heteroarylcarbamoylbenzene derivatives for the treatment of diabetes
CA2626475A1 (en) 2005-11-03 2007-05-10 Prosidion Limited Tricyclo substituted amides
US20080293741A1 (en) 2005-11-03 2008-11-27 Matthew Colin Thor Fyfe Tricyclo Substituted Amides as Glucokinase Modulators
JP2009514836A (ja) 2005-11-03 2009-04-09 プロシディオン・リミテッド トリシクロ置換型アミド
JP2009544648A (ja) * 2006-07-24 2009-12-17 エフ.ホフマン−ラ ロシュ アーゲー グルコキナーゼ活性化剤としてのピラゾール類
WO2008084872A1 (ja) * 2007-01-10 2008-07-17 Mitsubishi Tanabe Pharma Corporation ヒドラゾン誘導体
CN102089291B (zh) 2008-04-28 2016-08-17 杏林制药株式会社 环戊基丙烯酰胺衍生物

Similar Documents

Publication Publication Date Title
JP2009545527A5 (cg-RX-API-DMAC10.html)
JP2013525444A5 (cg-RX-API-DMAC10.html)
JP2009502743A5 (cg-RX-API-DMAC10.html)
JP2013518107A5 (cg-RX-API-DMAC10.html)
JP2011518833A5 (cg-RX-API-DMAC10.html)
JP2012255026A5 (cg-RX-API-DMAC10.html)
JP2013032389A5 (cg-RX-API-DMAC10.html)
JP2014515013A5 (cg-RX-API-DMAC10.html)
JP2013532687A5 (cg-RX-API-DMAC10.html)
JP2006526031A5 (cg-RX-API-DMAC10.html)
JP2007522220A5 (cg-RX-API-DMAC10.html)
JP2013542247A5 (cg-RX-API-DMAC10.html)
JP2009535462A5 (cg-RX-API-DMAC10.html)
JP2011102304A5 (cg-RX-API-DMAC10.html)
JP2012532874A5 (cg-RX-API-DMAC10.html)
JP2013509429A5 (cg-RX-API-DMAC10.html)
JP2007302689A5 (cg-RX-API-DMAC10.html)
JP2009502793A5 (cg-RX-API-DMAC10.html)
JP2012144574A5 (cg-RX-API-DMAC10.html)
JP2020097577A5 (cg-RX-API-DMAC10.html)
JP2015501783A5 (cg-RX-API-DMAC10.html)
JP2014500861A5 (cg-RX-API-DMAC10.html)
JP2006514012A5 (cg-RX-API-DMAC10.html)
JP2011105738A5 (cg-RX-API-DMAC10.html)
JP2013522326A5 (cg-RX-API-DMAC10.html)